0.99 USD
▲+0.00+10.61%
盘后 0.90 +1.47%
2026-08-03
市值
$88.25M
市盈率
—
EPS
-0.25
股息率
—
52 周区间
0.55 – 3.83
成交量
733.82K
Beta
1.78
目标价
3.50
52W 低 0.5552W 高 3.83
价格走势
公司简介
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studies for the treatment of Alzheimer’s disease and Mild Cognitive Impairment, as well as geographic atr...